RAC2 and B-cell chronic lymphocytic leukemia: However, in chronic lymphocytic leukemia (CLL) cells with NOTCH1 mutations, RAC2 appears to function downstream of NOTCH signaling as inhibition of the NOTCH pathway with PF-03084014 leads to downregulation of RAC2 along with other genes involved in invasion and chemotaxis [39].